Literature DB >> 29303807

Mucus Microbiome of Anastomotic Tissue During Surgery Has Predictive Value for Colorectal Anastomotic Leakage.

Jasper B van Praagh1, Marcus C de Goffau2,3, Ilsalien S Bakker1,4, Harry van Goor5, Hermie J M Harmsen2, Peter Olinga6, Klaas Havenga1.   

Abstract

OBJECTIVE: The aim of the present study is to investigate the association of gut microbiota, depending on treatment method, with the development of colorectal anastomotic leakage (AL).
BACKGROUND: AL is a major cause for morbidity and mortality after colorectal surgery, but the mechanism behind this complication still is not fully understood.
METHODS: Bacterial DNA was isolated from 123 "donuts" of patients where a stapled colorectal anastomosis was made and was analyzed using 16S MiSeq sequencing. In 63 patients, this anastomosis was covered with a C-seal, a bioresorbable sheath stapled to the anastomosis.
RESULTS: In non-C-seal patients, AL development was associated with low microbial diversity (P = 0.002) and correspondingly with a high abundance of the dominant Bacteroidaceae and Lachnospiraceae families (P = 0.008 and 0.010, respectively). In C-seal samples, where AL rates were slightly higher (25% vs 17%), an association with the gut microbiota composition was almost undetectable. Only a few opportunistic pathogenic groups of low abundance were associated with AL in C-seal patients, in particular Prevotella oralis (P = 0.007).
CONCLUSIONS: AL in patients without a C-seal can be linked to the intestinal microbiota, in particular with a low microbial diversity and a higher abundance of especially mucin-degrading members of the Bacteroidaceae and Lachnospiraceae families. In C-seal patients, however, it seems that any potential protective benefits or harmful consequences of the gut microbiota composition in regard to wound healing are negated, as progression to AL is independent of the initially dominant bacterial composition.

Entities:  

Year:  2019        PMID: 29303807     DOI: 10.1097/SLA.0000000000002651

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  19 in total

1.  Mucosal cancer-associated microbes and anastomotic leakage after resection of colorectal carcinoma.

Authors:  Kosuke Mima; Yuki Sakamoto; Keisuke Kosumi; Yoko Ogata; Keisuke Miyake; Yukiharu Hiyoshi; Takatsugu Ishimoto; Masaaki Iwatsuki; Yoshifumi Baba; Shiro Iwagami; Yuji Miyamoto; Naoya Yoshida; Shuji Ogino; Hideo Baba
Journal:  Surg Oncol       Date:  2019-11-18       Impact factor: 3.279

Review 2.  SSAT State-of-the-Art Conference: Advancements in the Microbiome.

Authors:  Miquell O Miller; Purna C Kashyap; Sarah L Becker; Ryan M Thomas; Richard A Hodin; George Miller; Mautin Hundeyin; Smruti Pushalkar; Deirdre Cohen; Deepak Saxena; Benjamin D Shogan; Gareth J Morris-Stiff
Journal:  J Gastrointest Surg       Date:  2021-07       Impact factor: 3.452

3.  Role of preoperative gut microbiota on colorectal anastomotic leakage: preliminary results.

Authors:  Silvia Palmisano; Giuseppina Campisciano; Cristiana Iacuzzo; Laura Bonadio; Annalisa Zucca; Davide Cosola; Manola Comar; Nicolò de Manzini
Journal:  Updates Surg       Date:  2020-02-15

4.  Bacterial Microbiome Dynamics in Post Pull-Through Hirschsprung-Associated Enterocolitis (HAEC): An Experimental Study Employing the Endothelin Receptor B-Null Mouse Model.

Authors:  Zhi Cheng; Lifu Zhao; Deepti Dhall; Paul M Ruegger; James Borneman; Philip K Frykman
Journal:  Front Surg       Date:  2018-04-06

Review 5.  Predictive factors for anastomotic leakage after laparoscopic colorectal surgery.

Authors:  Antonio Sciuto; Giovanni Merola; Giovanni D De Palma; Maurizio Sodo; Felice Pirozzi; Umberto M Bracale; Umberto Bracale
Journal:  World J Gastroenterol       Date:  2018-06-07       Impact factor: 5.742

Review 6.  Intestinal Microbiota: A Novel Target to Improve Anti-Tumor Treatment?

Authors:  Romain Villéger; Amélie Lopès; Guillaume Carrier; Julie Veziant; Elisabeth Billard; Nicolas Barnich; Johan Gagnière; Emilie Vazeille; Mathilde Bonnet
Journal:  Int J Mol Sci       Date:  2019-09-17       Impact factor: 5.923

7.  Therapeutic methods of gut microbiota modification in colorectal cancer management - fecal microbiota transplantation, prebiotics, probiotics, and synbiotics.

Authors:  Karolina Kaźmierczak-Siedlecka; Agnieszka Daca; Mateusz Fic; Thierry van de Wetering; Marcin Folwarski; Wojciech Makarewicz
Journal:  Gut Microbes       Date:  2020-05-26

Review 8.  Gut Microbiota as Potential Biomarker and/or Therapeutic Target to Improve the Management of Cancer: Focus on Colibactin-Producing Escherichia coli in Colorectal Cancer.

Authors:  Julie Veziant; Romain Villéger; Nicolas Barnich; Mathilde Bonnet
Journal:  Cancers (Basel)       Date:  2021-05-05       Impact factor: 6.639

Review 9.  The role of gut microbiota in cancer treatment: friend or foe?

Authors:  Wing Yin Cheng; Chun-Ying Wu; Jun Yu
Journal:  Gut       Date:  2020-08-05       Impact factor: 23.059

10.  Role of the intestinal microbiome in colorectal cancer surgery outcomes.

Authors:  Lelde Lauka; Elisa Reitano; Maria Clotilde Carra; Federica Gaiani; Paschalis Gavriilidis; Francesco Brunetti; Gian Luigi de'Angelis; Iradj Sobhani; Nicola de'Angelis
Journal:  World J Surg Oncol       Date:  2019-12-02       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.